142 related articles for article (PubMed ID: 37311751)
1. Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma.
Saillard C; Delecourt F; Schmauch B; Moindrot O; Svrcek M; Bardier-Dupas A; Emile JF; Ayadi M; Rebours V; de Mestier L; Hammel P; Neuzillet C; Bachet JB; Iovanna J; Dusetti N; Blum Y; Richard M; Kermezli Y; Paradis V; Zaslavskiy M; Courtiol P; Kamoun A; Nicolle R; Cros J
Nat Commun; 2023 Jun; 14(1):3459. PubMed ID: 37311751
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
Zhao L; Zhao H; Yan H
BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
[TBL] [Abstract][Full Text] [Related]
3. Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics.
Topham JT; Karasinska JM; Lee MKC; Csizmok V; Williamson LM; Jang GH; Denroche RE; Tsang ES; Kalloger SE; Wong HL; O'Kane GM; Moore RA; Mungall AJ; Notta F; Loree JM; Wilson JM; Bathe O; Tang PA; Goodwin R; Knox JJ; Gallinger S; Laskin J; Marra MA; Jones SJM; Renouf DJ; Schaeffer DF
Clin Cancer Res; 2021 Jan; 27(1):150-157. PubMed ID: 33051307
[TBL] [Abstract][Full Text] [Related]
4. Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome.
N Kalimuthu S; Wilson GW; Grant RC; Seto M; O'Kane G; Vajpeyi R; Notta F; Gallinger S; Chetty R
Gut; 2020 Feb; 69(2):317-328. PubMed ID: 31201285
[TBL] [Abstract][Full Text] [Related]
5. A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis.
Mohamed Abd-El-Halim Y; El Kaoutari A; Silvy F; Rubis M; Bigonnet M; Roques J; Cros J; Nicolle R; Iovanna J; Dusetti N; Mas E
EBioMedicine; 2021 Sep; 71():103541. PubMed ID: 34425307
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma.
Birnbaum DJ; Begg SKS; Finetti P; Vanderburg C; Kulkarni AS; Neyaz A; Hank T; Tai E; Deshpande V; Bertucci F; Birnbaum D; Lillemoe KD; Warshaw AL; Mino-Kenudson M; Fernandez-Del Castillo C; Ting DT; Liss AS
Clin Cancer Res; 2021 Apr; 27(8):2314-2325. PubMed ID: 33547202
[TBL] [Abstract][Full Text] [Related]
7. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.
Moffitt RA; Marayati R; Flate EL; Volmar KE; Loeza SG; Hoadley KA; Rashid NU; Williams LA; Eaton SC; Chung AH; Smyla JK; Anderson JM; Kim HJ; Bentrem DJ; Talamonti MS; Iacobuzio-Donahue CA; Hollingsworth MA; Yeh JJ
Nat Genet; 2015 Oct; 47(10):1168-78. PubMed ID: 26343385
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analysis reveals pancreatic cancer molecular subtypes specific to the tumor and the microenvironment.
Le Large TY; Mato Prado M; Krell J; Bijlsma MF; Meijer LL; Kazemier G; Frampton AE; Giovannetti E
Expert Rev Mol Diagn; 2016 Jul; 16(7):733-6. PubMed ID: 27118062
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
[TBL] [Abstract][Full Text] [Related]
10. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens.
Rasmussen LG; Verbeke CS; Sørensen MD; Pfeiffer P; Tan Q; Mortensen MB; Fristrup C; Detlefsen S
Pancreatology; 2021 Apr; 21(3):530-543. PubMed ID: 33637450
[TBL] [Abstract][Full Text] [Related]
12. Unsupervised subtyping and methylation landscape of pancreatic ductal adenocarcinoma.
Roy S; Singh AP; Gupta D
Heliyon; 2021 Jan; 7(1):e06000. PubMed ID: 33521362
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer survival analysis defines a signature that predicts outcome.
Raman P; Maddipati R; Lim KH; Tozeren A
PLoS One; 2018; 13(8):e0201751. PubMed ID: 30092011
[TBL] [Abstract][Full Text] [Related]
14. Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinoma.
Hilmi M; Cros J; Puleo F; Augustin J; Emile JF; Svrcek M; Hammel P; Arsenijevic T; Van Laethem JL; Bachet JB; Nicolle R
Eur J Cancer; 2021 May; 148():171-180. PubMed ID: 33743485
[TBL] [Abstract][Full Text] [Related]
15. Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma.
Zhao JG; Li YJ; Wu Y; Zhang K; Peng LJ; Chen H
BMC Med Genomics; 2023 May; 16(1):106. PubMed ID: 37198621
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma.
Damhofer H; Medema JP; Veenstra VL; Badea L; Popescu I; Roelink H; Bijlsma MF
Mol Oncol; 2013 Dec; 7(6):1031-42. PubMed ID: 23998958
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.
Li R; He Y; Zhang H; Wang J; Liu X; Liu H; Wu H; Liang Z
Front Immunol; 2021; 12():690056. PubMed ID: 34335594
[TBL] [Abstract][Full Text] [Related]
18. GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.
O'Kane GM; Grünwald BT; Jang GH; Masoomian M; Picardo S; Grant RC; Denroche RE; Zhang A; Wang Y; Lam B; Krzyzanowski PM; Lungu IM; Bartlett JMS; Peralta M; Vyas F; Khokha R; Biagi J; Chadwick D; Ramotar S; Hutchinson S; Dodd A; Wilson JM; Notta F; Zogopoulos G; Gallinger S; Knox JJ; Fischer SE
Clin Cancer Res; 2020 Sep; 26(18):4901-4910. PubMed ID: 32156747
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of the classical phenotype upon integration of pancreatic cancer cells into the duodenal epithelium.
Bozóky B; Fernández Moro C; Strell C; Geyer N; Heuchel RL; Löhr JM; Ernberg I; Szekely L; Gerling M; Bozóky B
Neoplasia; 2021 Dec; 23(12):1300-1306. PubMed ID: 34798385
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma.
Duconseil P; Gilabert M; Gayet O; Loncle C; Moutardier V; Turrini O; Calvo E; Ewald J; Giovannini M; Gasmi M; Bories E; Barthet M; Ouaissi M; Goncalves A; Poizat F; Raoul JL; Secq V; Garcia S; Viens P; Iovanna J; Dusetti N
Am J Pathol; 2015 Apr; 185(4):1022-32. PubMed ID: 25765988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
